Risk relationship between dyslipemia and COVID-19
The presence of dyslipemia in patients with COVID-19 seems to increase the clinical course of the disease. In this literature review the main mechanisms that link them and their implications in the treatment of the affected patients are described. To carry out this work a literature search was made...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas
2022-09-01
|
Series: | Medisan |
Subjects: | |
Online Access: | http://medisan.sld.cu/index.php/san/article/view/3999 |
_version_ | 1818065133527629824 |
---|---|
author | Izaida Lis Montero López Wardy Castillo López Silvio Niño Escofet Pedro Enrique Miguel Soca |
author_facet | Izaida Lis Montero López Wardy Castillo López Silvio Niño Escofet Pedro Enrique Miguel Soca |
author_sort | Izaida Lis Montero López |
collection | DOAJ |
description | The presence of dyslipemia in patients with COVID-19 seems to increase the clinical course of the disease. In this literature review the main mechanisms that link them and their implications in the treatment of the affected patients are described. To carry out this work a literature search was made in databases, such as academic Google, SciELO, Annual Reviews and PMC. The analyzed describers were COVID-19, SARS-CoV-2, dyslipemia, LDL-cholesterol, HDL-cholesterol, triglycerides, hypercholesterolemia and VLDL lipoproteins. Articles of magazines arbitrated by pairs and available to complete text, published in English and Spanish were preferably revised. In spite of the controversies, dyslipemia is a risk factor of unfavorable prognosis in patients affected with COVID-19 and the treatment for the patients with that unfavourable condition improve this prognosis. |
first_indexed | 2024-12-10T14:47:03Z |
format | Article |
id | doaj.art-71c24d0c52f94a73a6069689b86237fc |
institution | Directory Open Access Journal |
issn | 1029-3019 |
language | Spanish |
last_indexed | 2024-12-10T14:47:03Z |
publishDate | 2022-09-01 |
publisher | Centro Provincial de Información de Ciencias Médicas |
record_format | Article |
series | Medisan |
spelling | doaj.art-71c24d0c52f94a73a6069689b86237fc2022-12-22T01:44:33ZspaCentro Provincial de Información de Ciencias MédicasMedisan1029-30192022-09-01264e3999e39991192Risk relationship between dyslipemia and COVID-19Izaida Lis Montero López0Wardy Castillo López1Silvio Niño Escofet2Pedro Enrique Miguel Soca3Escuela Superior Politécnica de Chimborazo. Riobamba, ChimborazoEscuela Superior Politécnica de Chimborazo. Riobamba, ChimborazoUniversidad de Ciencias Médicas de Holguín. HolguínUniversidad de Ciencias Médicas de Holguín. HolguínThe presence of dyslipemia in patients with COVID-19 seems to increase the clinical course of the disease. In this literature review the main mechanisms that link them and their implications in the treatment of the affected patients are described. To carry out this work a literature search was made in databases, such as academic Google, SciELO, Annual Reviews and PMC. The analyzed describers were COVID-19, SARS-CoV-2, dyslipemia, LDL-cholesterol, HDL-cholesterol, triglycerides, hypercholesterolemia and VLDL lipoproteins. Articles of magazines arbitrated by pairs and available to complete text, published in English and Spanish were preferably revised. In spite of the controversies, dyslipemia is a risk factor of unfavorable prognosis in patients affected with COVID-19 and the treatment for the patients with that unfavourable condition improve this prognosis.http://medisan.sld.cu/index.php/san/article/view/3999covid-19sars-cov-2dislipidemialdl-colesterolhdl-colesterol triglicéridoshipercolesterolemialipoproteínas vldl. |
spellingShingle | Izaida Lis Montero López Wardy Castillo López Silvio Niño Escofet Pedro Enrique Miguel Soca Risk relationship between dyslipemia and COVID-19 Medisan covid-19 sars-cov-2 dislipidemia ldl-colesterol hdl-colesterol triglicéridos hipercolesterolemia lipoproteínas vldl. |
title | Risk relationship between dyslipemia and COVID-19 |
title_full | Risk relationship between dyslipemia and COVID-19 |
title_fullStr | Risk relationship between dyslipemia and COVID-19 |
title_full_unstemmed | Risk relationship between dyslipemia and COVID-19 |
title_short | Risk relationship between dyslipemia and COVID-19 |
title_sort | risk relationship between dyslipemia and covid 19 |
topic | covid-19 sars-cov-2 dislipidemia ldl-colesterol hdl-colesterol triglicéridos hipercolesterolemia lipoproteínas vldl. |
url | http://medisan.sld.cu/index.php/san/article/view/3999 |
work_keys_str_mv | AT izaidalismonterolopez riskrelationshipbetweendyslipemiaandcovid19 AT wardycastillolopez riskrelationshipbetweendyslipemiaandcovid19 AT silvioninoescofet riskrelationshipbetweendyslipemiaandcovid19 AT pedroenriquemiguelsoca riskrelationshipbetweendyslipemiaandcovid19 |